SEC charges former NBTY counsel
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Securities & Exchange Commission filed insider trading charges against former NBTY associate general counsel Mitchell Drucker and his father Ronald Drucker March 2, the commission announces. According to the complaint filed in federal court for the southern district of New York, Mitchell Drucker sold of all his NBTY stock on Oct. 18, 2001 after learning that the firm's fourth-quarter earnings would be 50% lower than analysts had previously predicted. The information was not publicly released until the following day. Mitchell Drucker also instructed his father to sell his shares and oversaw the sale of all of a friend's shares in the firm. Mitchell and Ronald Drucker avoided losses of $138,174 and $51,116, respectively. In addition to the disgorgement of losses avoided and civil penalties, SEC also is asking that the court bar Mitchell Drucker from acting as an officer or director of a public company...
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.